121 related articles for article (PubMed ID: 22242803)
1. Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data.
Ceriello A; Cremasco F; Romoli E; Rossi A; Gentilella R
Expert Opin Pharmacother; 2012 Feb; 13(2):255-81. PubMed ID: 22242803
[TBL] [Abstract][Full Text] [Related]
2. Use of Insulin Lispro Protamine Suspension in Pregnancy.
Lapolla A; Dalfrà MG; Romoli E; Bonomo M; Moghetti P
Adv Ther; 2015 Oct; 32(10):888-905. PubMed ID: 26499176
[TBL] [Abstract][Full Text] [Related]
3. Humalog (lispro) for type 2 diabetes.
Esposito K; Capuano A; Giugliano D
Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes.
Hompesch M; Ocheltree SM; Wondmagegnehu ET; Morrow LA; Kollmeier AP; Campaigne BN; Jacober SJ
Curr Med Res Opin; 2009 Nov; 25(11):2679-87. PubMed ID: 19761358
[TBL] [Abstract][Full Text] [Related]
5. Basal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for type 2 diabetes: meta-analysis of randomized controlled trials.
Esposito K; Chiodini P; Capuano A; Petrizzo M; Improta MR; Giugliano D
Diabetes Care; 2012 Dec; 35(12):2698-705. PubMed ID: 23173139
[TBL] [Abstract][Full Text] [Related]
6. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
[TBL] [Abstract][Full Text] [Related]
7. Premixed insulin analogues for the treatment of diabetes mellitus.
Garber AJ
Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
[TBL] [Abstract][Full Text] [Related]
8. Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study.
Dalfrà MG; Soldato A; Moghetti P; Lombardi S; Vinci C; De Cata AP; Romanelli T; Bonomo M; Sciacca L; Tata F; Ragazzi E; Filippi A; Burlina S; Lapolla A
J Matern Fetal Neonatal Med; 2016; 29(7):1061-5. PubMed ID: 25817082
[TBL] [Abstract][Full Text] [Related]
9. 20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.
Kaiserman K; Jung H; Benabbad I; Karges B; Polak M; Rosilio M
Pediatr Diabetes; 2017 Mar; 18(2):81-94. PubMed ID: 27390032
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
Roach P; Woodworth JR
Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
[TBL] [Abstract][Full Text] [Related]
11. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
Dunn CJ; Plosker GL
Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes.
Ocheltree SM; Hompesch M; Wondmagegnehu ET; Morrow L; Win K; Jacober SJ
Eur J Endocrinol; 2010 Aug; 163(2):217-23. PubMed ID: 20508081
[TBL] [Abstract][Full Text] [Related]
13. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
14. Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
Andersen G; Meiffren G; Lamers D; DeVries JH; Ranson A; Seroussi C; Alluis B; Gaudier M; Soula O; Heise T
Diabetes Obes Metab; 2018 Nov; 20(11):2627-2632. PubMed ID: 29923294
[TBL] [Abstract][Full Text] [Related]
15. SAR342434 - an insulin biosimilar for the treatment of type II diabetes.
Hu J; Wang M; Zhao Y
Expert Opin Biol Ther; 2018 Nov; 18(11):1107-1112. PubMed ID: 30295083
[TBL] [Abstract][Full Text] [Related]
16. [New insulin types in type 1 diabetes mellitus].
Mesa J
Med Clin (Barc); 2015 Jul; 145(2):70-5. PubMed ID: 25200067
[TBL] [Abstract][Full Text] [Related]
17. Insulin analogs in the treatment of type II diabetes and future perspectives.
Sebastian SA; Co EL; Mehendale M; Hameed M
Dis Mon; 2023 Mar; 69(3):101417. PubMed ID: 35487767
[TBL] [Abstract][Full Text] [Related]
18. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes.
Giugliano D; Esposito K
Ther Adv Endocrinol Metab; 2012 Jun; 3(3):99-108. PubMed ID: 23148201
[TBL] [Abstract][Full Text] [Related]
20. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
